Abstract
摘要
相似文献
1
[Not Available].[无可用内容]
Rev Med Suisse. 2020 Mar 11;16(685):510-511.
2
Of chloroquine and COVID-19.关于氯喹和 COVID-19。
Antiviral Res. 2020 May;177:104762. doi: 10.1016/j.antiviral.2020.104762. Epub 2020 Mar 5.
3
Chloroquine and COVID-19, where do we stand?氯喹与新型冠状病毒肺炎，我们目前的情况如何？
Med Mal Infect. 2020 May;50(3):229-230. doi: 10.1016/j.medmal.2020.03.004. Epub 2020 Mar 27.
4
Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.用于治疗新冠肺炎的氯喹/羟氯喹引发室性心律失常的风险：是否应该使用该药？
Indian Heart J. 2020 Mar-Apr;72(2):131-132. doi: 10.1016/j.ihj.2020.04.006. Epub 2020 Apr 27.
5
COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?2019冠状病毒病与氯喹/羟氯喹：是否存在眼科方面的问题？
Am J Ophthalmol. 2020 Aug;216:A1-A2. doi: 10.1016/j.ajo.2020.03.029. Epub 2020 May 8.
6
COVID-19: Stay Cool toward Corticosteroids.新冠疫情：对皮质类固醇保持冷静态度。
Keio J Med. 2020 Jun 25;69(2):27-29. doi: 10.2302/kjm.2020-0007-LE. Epub 2020 May 30.
7
Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.使用多梳蛋白抑制剂作为抗病毒药物靶向严重急性呼吸综合征冠状病毒2（SARS-CoV-2）
Epigenomics. 2020 May;12(10):811-812. doi: 10.2217/epi-2020-0154. Epub 2020 Jun 4.
8
[Chloroquine as a possible treatment for COVID-19].[氯喹作为新型冠状病毒肺炎的一种可能治疗方法]
Ned Tijdschr Geneeskd. 2020 Mar 11;164:D4936.
9
Novel Coronavirus (SARS-CoV-2) resistance in African populations: A cause worth exploring.非洲人群对新型冠状病毒（SARS-CoV-2）的抵抗力：一个值得探索的原因。
Acta Biomed. 2020 Sep 7;91(3):e2020023. doi: 10.23750/abm.v91i3.9872.
10
Importance of Environmental Factors on Production of Computationally- Defined Natural Molecules against COVID-19 Pandemic.环境因素对针对新冠疫情生成计算定义的天然分子的重要性。
Curr Top Med Chem. 2020;20(22):1958-1961. doi: 10.2174/156802662022200917110430.
引用本文的文献
1
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.氯喹或羟氯喹预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 12;2(2):CD013587. doi: 10.1002/14651858.CD013587.pub2.
Zotero 插件